Andrew O’Connor to Lead Roundtable on SOM Program Challenges at Controlled Substances Summit

Event
January 26, 2026

Andrew O’Connor, co-leader of the healthcare and life sciences industry group and the Chambers Band 1–ranked False Claims Act practice, will lead a discussion at the American Conference Institute's 7th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement.

The session, “Solving SOM Program Pain Points,” will be held on January 26, and will bring together industry peers for a conversation on building smarter, more efficient suspicious order monitoring (SOM) programs.

The session is part of the Summit’s series of high-impact, small-group roundtables designed to deliver actionable takeaways tailored to attendees’ roles and priorities.

Registration is available through the conference website.